(3-[(TERT-BUTYLDIMETHYLSILYL)OXY]CYCLOBUTYL)METHANOL, 95.0%, 5g

3-methyl-5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazole hydrochloride, 95.0%, 250mg

Methyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate, 97%, 250mg

Filtres pour seringues ROTILABO® Polytétrafluoroéthylène (PTFE), 0,2 µm, 25 mm, stérile, 100 pièce(s)

6-Methyl-2,4-dioxo-3-phenyl-1h,2h,3h,4h-furo[2,3-d]pyrimidine-5-carboxylic acid, 97%, 250mg

7-BROMO-4-CHLORO-1H-INDAZOLE, 95%, 500mg

2-AMINO-6-BROMO-4-CHLOROPHENOL, 95.0%, 5g

4-Methyl-1-phenyl-3-pyrazolidone>98.0%(HPLC)(T)25g

Objectif E-plan EPL 4x/0,10

Methyl 3-Hydroxyisoxazole-5-carboxylate>98.0%(GC)1g

2-Methyl-3-methylsulfanyl-pyrazine, 98.0%, 25g

tert-Butyl 3-bromo-4-fluorobenzylcarbamate, 5g

2-Amino-3,4-dimethylpyridine, 95.0%, 5g